Cat: IPD-X25752

Recombinant Mouse Biglycan Protein (HEK293),hFc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    Biglycan

  • 简介

    Biglycan proteins may be involved in collagen fiber assembly, suggesting a role in organizing and building collagen networks. Its involvement suggests a crucial function in extracellular matrix formation and maintenance. Biglycan Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived Biglycan protein, expressed by HEK293 , with C-hFc labeled tag.

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    Measured by its ability to inhibit the cell growth of mouse NIH-3T3 mouse embryonic fibroblast adipose-like cells. The ED50 for this effect is 0.5711 μg/mL, corresponding to a specific activity is 1.751×103units/mg. Measured by its ability to inhibit the cell growth of mouse NIH-3T3 mouse embryonic fibroblast adipose-like cells. The ED50 for this effect is 0.5711 μg/mL, corresponding to a specific activity is 1.751×103 units/mg.

  • Alternative Names

    Biglycan; BGN; SLRR1A

  • Species

    Mouse

  • Source

    HEK293

  • Tag

    C-hFc

  • Purity

    Greater than 95% as determined by SDS-PAGE.

  • Uniprot

    P28653

  • Expression Region

    D38-K369

  • AA Sequence

    DEEASGSDTTSGVPDLDSVTPTFSAMCPFGCHCHLRVVQCSDLGLKTVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHSNNITKVGINDFCPMGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYKK

  • Protein Length

    Full Length of Mature Protein

  • Molecular Weight

    75-100 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Biglycan is a small leucine-rich proteoglycan that plays a crucial role in the regulation of collagen fibril formation and the maintenance of extracellular matrix integrity. As a member of the small leucine-rich proteoglycan family, it is primarily found in connective tissues and has been implicated in various biological processes, including wound healing, inflammation, and tumor progression. Research on recombinant biglycan protein has gained significance due to its potential therapeutic applications in regenerative medicine and tissue engineering. By studying recombinant biglycan, scientists aim to elucidate its structural properties and functional roles in the extracellular matrix, which may pave the way for developing novel biomaterials that enhance tissue regeneration. Additionally, understanding the molecular mechanisms by which biglycan interacts with other extracellular matrix components can provide insights into the pathophysiology of various diseases, including osteoarthritis and cancer. As such, the development of recombinant biglycan not only offers opportunities for advanced biomaterial design but also opens up new avenues for targeted therapies that exploit its unique properties in modulating cellular behavior and tissue repair.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US